4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

The recent advances in technology combined with the need to manage patients remotely
during the coronavirus disease-19 (COVID-19) pandemic, have led to a rapid adaptation of …

Many widely used medications may cause or exacerbate a variety of arrhythmias. Numerous
antiarrhythmic agents, antimicrobial drugs, psychotropic medications, and methadone, as …

The Brugada syndrome is an inherited disorder associated with risk of ventricular fibrillation
and sudden cardiac death in a structurally normal heart. Diagnosis is based on a …

Brugada syndrome (BrS) is an “inherited” condition characterized by predisposition to
syncope and cardiac arrest, predominantly during sleep. The prevalence is∼ 1: 2,000, and …

BACKGROUND: Brugada syndrome poses significant challenges in terms of risk
stratification and management, particularly for asymptomatic patients who comprise the …

Youth and adult participation in sports continues to increase, and athletes may be
diagnosed with potentially arrhythmogenic cardiac conditions. This international …

Brugada syndrome (BrS) is an inherited ion channel channelopathy predisposing to
ventricular arrhythmias and sudden cardiac death. Originally believed to be predominantly …

Objectives Brugada syndrome (BrS) is an ion channelopathy that predisposes affected
patients to spontaneous ventricular tachycardia/fibrillation (VT/VF) and sudden cardiac …

Background Experience with implantable loop recorders (ILRs) in Brugada syndrome (BrS)
is limited. Objective The purpose of this study was to evaluate the indications and yield of …